Literature DB >> 2605781

Fragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexes.

A M Griffiths1, K E Herbert, D Perrett, D L Scott.   

Abstract

Fibronectin, an opsonic glycoprotein has been shown to exist in fragmented forms in serum and synovial fluid. Some fragments in synovial fluid appear to be polyethylene glycol (PEG) precipitable, suggesting incorporation into immune complexes (IC). PEG precipitation, SDS-PAGE and immunoblotting were used to determine whether PEG precipitable fragments are real or artefactual. Disease specificity of fragmentation and IC incorporation of fibronectin and other proteins were also studied using these techniques. PEG precipitable fragments do not appear to be artefactual, although some fibronectin fragments are cryoprecipitable. Protein fragments showed similar distributions in whole serum and synovial fluid, disease specific differences being confined to PEG precipitates. Rheumatoid arthritis (RA) synovial fluid PEG precipitates displayed the greatest array of fragmented immunoglobulins and fibronectin. No PEG precipitates contained albumin fragments. Protein fragments in IC may impair their effective removal from RA joints. Accumulated IC could lead to tissue damage via complement activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605781     DOI: 10.1016/0009-8981(89)90283-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Effect of fibronectin on the Crithidia luciliae test for anti-double-stranded DNA antibodies.

Authors:  K E Herbert; E Jeffery; D L Scott
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

2.  Synovial fluid fibronectin fragments: no evidence for a mitogenic effect on fibroblasts.

Authors:  K E Herbert; P I Mapp; A M Griffiths; P A Revell; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 3.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

4.  A single blunt impact on cartilage promotes fibronectin fragmentation and upregulates cartilage degrading stromelysin-1/matrix metalloproteinase-3 in a bovine ex vivo model.

Authors:  Lei Ding; Danping Guo; Gene A Homandberg; Joseph A Buckwalter; James A Martin
Journal:  J Orthop Res       Date:  2014-03-07       Impact factor: 3.494

5.  The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.

Authors:  Heather Stanton; Linh Ung; Amanda J Fosang
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

6.  Localisation of fibronectin mRNA in the rheumatoid synovium by in situ hybridisation.

Authors:  H A Waller; M G Butler; J G McClean; G S Dowd; D L Scott
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

7.  Disease-associated extracellular matrix suppresses osteoblastic differentiation of human periodontal ligament cells via MMP-1.

Authors:  Jeena Joseph; Yvonne L Kapila; Takayuki Hayami; Sunil Kapila
Journal:  Calcif Tissue Int       Date:  2009-12-02       Impact factor: 4.333

8.  Porphyromonas gingivalis, gamma interferon, and a proapoptotic fibronectin matrix form a synergistic trio that induces c-Jun N-terminal kinase 1-mediated nitric oxide generation and cell death.

Authors:  Abhijit Ghosh; Ji Young Park; Christopher Fenno; Yvonne L Kapila
Journal:  Infect Immun       Date:  2008-10-06       Impact factor: 3.441

9.  A Comparative Study of Fibronectin Cleavage by MMP-1, -3, -13, and -14.

Authors:  Xiaorong Zhang; Christopher T Chen; Madhu Bhargava; Peter A Torzilli
Journal:  Cartilage       Date:  2012-07       Impact factor: 4.634

10.  Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis.

Authors:  John H Peters; Steven Carsons; Mika Yoshida; Fred Ko; Skye McDougall; Grace A Loredo; Theodore J Hahn
Journal:  Arthritis Res Ther       Date:  2003-09-08       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.